| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |